Challenges and future perspectives in using mesenchymal stem cells for efficient bone fracture healing

Area of Science:

• Orthopedics and Regenerative Medicine
• Cell Biology and Immunology

Background:

• Mesenchymal stem cells (MSCs) possess multipotency and immunomodulatory properties, crucial for bone fracture healing.
• Bone healing involves complex interactions between immune cells, MSCs, and the skeletal microenvironment, mediated by cytokines and signaling pathways.
• MSC therapeutic potential is hindered by source variability, ethical concerns, regulatory issues, and delivery challenges.

Purpose of the Study:

• To review the relationship between MSCs, the immune system, and the skeletal microenvironment in osteogenesis.
• To explore the role of cytokines and signaling pathways in MSC-mediated bone repair.
• To discuss advancements and limitations in MSC-based therapies for bone regeneration.

Main Methods:

• Literature review focusing on MSCs, immune system interactions, and skeletal microenvironment.
• Analysis of cytokines and signaling pathways involved in osteogenesis and inflammation.
• Examination of current and emerging MSC-based therapeutic strategies and their challenges.

Main Results:

• MSCs secrete bioactive molecules that promote tissue regeneration and modulate inflammation during bone healing.
• Age-related decline in MSC functionality impacts fracture healing, necessitating strategies for MSC rejuvenation.
• Innovations like biomaterials, 3D bioprinting, and gene editing aim to enhance MSC therapeutic efficacy.

Conclusions:

• Understanding MSC mechanisms, including paracrine signaling and microenvironment interactions, is vital for optimizing therapeutic use.
• Addressing current limitations in MSC research and application is essential for advancing bone repair therapies.
• MSCs hold transformative potential in regenerative medicine and orthopedics, requiring further investigation to improve clinical outcomes for bone injuries.